Jefferies Group LLC Blueprint Medicines Corp Put Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $2.28 Million - $2.72 Million	-25,100 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$92.08 - $124.48 $2.31 Million - $3.12 Million	25,100 New	25,100 $2.81 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $4.25 Million - $5.75 Million	-46,200 Reduced 64.8%	25,100 $2.82 Million
Q3 2020 Nov 13, 2020	BUY	$66.45 - $92.7 $1.34 Million - $1.86 Million	20,100 Added 39.26%	71,300 $6.61 Million
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $1.18 Million - $1.64 Million	-20,700 Reduced 28.79%	51,200 $3.99 Million
Q1 2020 May 15, 2020	SELL	$48.11 - $82.22 $48,110 - $82,220	-1,000 Reduced 1.37%	71,900 $4.21 Million
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $2.46 Million - $3.05 Million	36,900 Added 102.5%	72,900 $5.84 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $2.65 Million - $3.52 Million	36,000 New	36,000 $3.4 Million

350

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.57B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.